Preclinical evaluation of the Aurora kinase inhibitors AMG 900, AZD1152-HQPA, and MK-5108 on SW-872 and 93T449 human liposarcoma cells
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preclinical evaluation of the Aurora kinase inhibitors AMG 900, AZD1152-HQPA, and MK-5108 on SW-872 and 93T449 human liposarcoma cells
Authors
Keywords
Aurora kinase inhibitors, Liposarcoma, AMG 900, AZD1152-HQPA, MK-5108, SW-872 cell line, 93T449 cell line
Journal
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
Volume 54, Issue 1, Pages 71-84
Publisher
Springer Nature
Online
2017-12-02
DOI
10.1007/s11626-017-0208-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activity of trabectedin and the PARP inhibitor rucaparib in soft-tissue sarcomas
- (2017) Audrey Laroche et al. Journal of Hematology & Oncology
- Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcoma
- (2016) M. A. Dickson et al. ANNALS OF ONCOLOGY
- Liposarcoma: molecular targets and therapeutic implications
- (2016) Kate Lynn J. Bill et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) Trial
- (2016) Steven G. DuBois et al. JOURNAL OF CLINICAL ONCOLOGY
- Barasertib (AZD1152), a Small Molecule Aurora B Inhibitor, Inhibits the Growth of SCLC Cell Lines In Vitro and In Vivo
- (2016) B. A. Helfrich et al. MOLECULAR CANCER THERAPEUTICS
- Liposarcoma
- (2016) Aimee M. Crago et al. Surgical Oncology Clinics of North America
- Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas
- (2016) Alessandro De Vita et al. OncoTargets and Therapy
- MLN-8237: A dual inhibitor of aurora A and B in soft tissue sarcomas
- (2016) Jayasree S. Nair et al. Oncotarget
- Ubiquitin-Mediated Degradation of Aurora Kinases
- (2016) Catherine Lindon et al. Frontiers in Oncology
- Aurora Kinase B Protein Is Overexpressed in High-Grade Sarcomas:A Pilot Study
- (2016) Sandhya Noronha et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Involvement of tumor suppressors PTEN and p53 in the formation of multiple subtypes of liposarcoma
- (2015) A M Puzio-Kuter et al. CELL DEATH AND DIFFERENTIATION
- SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma
- (2015) K. L. J. Bill et al. CLINICAL CANCER RESEARCH
- Liposarcoma in animals
- (2015) Georgina Doria-Torra et al. JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION
- Aurora Kinase Inhibitors in Oncology Clinical Trials: Current State of the Progress
- (2015) Gerald S. Falchook et al. SEMINARS IN ONCOLOGY
- A Cell Biologist’s Field Guide to Aurora Kinase Inhibitors
- (2015) Christian O. de Groot et al. Frontiers in Oncology
- Effects of selective inhibitors of Aurora kinases on anaplastic thyroid carcinoma cell lines
- (2014) E. Baldini et al. ENDOCRINE-RELATED CANCER
- Aurora kinase inhibitor patents and agents in clinical testing: an update (2011 – 2013)
- (2014) Chun Hei Antonio Cheung et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Current management options for liposarcoma and challenges for the future
- (2014) Attila Kollár et al. Expert Review of Anticancer Therapy
- Anticancer activity of the Aurora A kinase inhibitor MK-5108 in non-small-cell lung cancer (NSCLC) in vitro as monotherapy and in combination with chemotherapies
- (2014) Danielle C. Chinn et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- AZD1152-HQPA induces growth arrest and apoptosis in androgen-dependent prostate cancer cell line (LNCaP) via producing aneugenic micronuclei and polyploidy
- (2014) Ali Zekri et al. TUMOR BIOLOGY
- AMG 900, pan-Aurora kinase inhibitor, preferentially inhibits the proliferation of breast cancer cell lines with dysfunctional p53
- (2013) Ondrej Kalous et al. BREAST CANCER RESEARCH AND TREATMENT
- Liposarcomas
- (2013) Joern Henze et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- p53 deficiency enhances mitotic arrest and slippage induced by pharmacological inhibition of Aurora kinases
- (2013) M Marxer et al. ONCOGENE
- AURORA KINASES: STRUCTURE, FUNCTIONS AND THEIR ASSOCIATION WITH CANCER
- (2012) Madhu Kollareddy et al. BIOMEDICAL PAPERS-OLOMOUC
- Randomized phase II study of danusertib in patients with metastatic castration-resistant prostate cancer after docetaxel failure
- (2012) Hielke J. Meulenbeld et al. BJU INTERNATIONAL
- Phase I study of the Aurora B kinase inhibitor barasertib (AZD1152) to assess the pharmacokinetics, metabolism and excretion in patients with acute myeloid leukemia
- (2012) Mike Dennis et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase II study of MLN8237 (alisertib), an investigational Aurora A kinase inhibitor, in patients with platinum-resistant or -refractory epithelial ovarian, fallopian tube, or primary peritoneal carcinoma
- (2012) Ursula A. Matulonis et al. GYNECOLOGIC ONCOLOGY
- MK-0457, an Aurora kinase and BCR–ABL inhibitor, is active in patients with BCR–ABL T315I leukemia
- (2012) F J Giles et al. LEUKEMIA
- The chromosomal passenger complex (CPC): from easy rider to the godfather of mitosis
- (2012) Mar Carmena et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Phase 1/2 study to assess the safety, efficacy, and pharmacokinetics of barasertib (AZD1152) in patients with advanced acute myeloid leukemia
- (2011) B. Lowenberg et al. BLOOD
- Pleomorphic liposarcoma
- (2011) Markus P. Ghadimi et al. CANCER
- The Aurora B kinase inhibitor AZD1152 sensitizes cancer cells to fractionated irradiation and induces mitotic catastrophe
- (2011) Yungan Tao et al. CELL CYCLE
- Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma
- (2011) Aimee M Crago et al. CURRENT OPINION IN ONCOLOGY
- A Phase I study to assess the safety, pharmacokinetics and efficacy of barasertib (AZD1152), an Aurora B kinase inhibitor, in Japanese patients with advanced acute myeloid leukemia
- (2011) Kosuke Tsuboi et al. LEUKEMIA RESEARCH
- Preclinical Evaluation of AMG 900, a Novel Potent and Highly Selective Pan-Aurora Kinase Inhibitor with Activity in Taxane-Resistant Tumor Cell Lines
- (2010) M. Payton et al. CANCER RESEARCH
- Future treatment of soft tissue sarcomas will be driven by histological subtype and molecular abberations
- (2010) Jaap Verweij et al. EUROPEAN JOURNAL OF CANCER
- MK-5108, a Highly Selective Aurora-A Kinase Inhibitor, Shows Antitumor Activity Alone and in Combination with Docetaxel
- (2010) T. Shimomura et al. MOLECULAR CANCER THERAPEUTICS
- Expression of Aurora B and alternative variant forms in hepatocellular carcinoma and adjacent tissue
- (2009) Mahmut Yasen et al. CANCER SCIENCE
- Characterization and comparison of the properties of sarcoma cell linesin vitroandin vivo
- (2009) Joslyn MILLS et al. Human Cell
- Granulocytic differentiation of HL-60 promyelocytic leukemia cells is associated with increased expression of Cul5
- (2009) Shaneen S. Baxter et al. IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
- Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma
- (2008) Vasilios Karavasilis et al. CANCER
- Variability of origin for the neocentromeric sequences in analphoid supernumerary marker chromosomes of well-differentiated liposarcomas
- (2008) Antoine Italiano et al. CANCER LETTERS
- Analyzing real-time PCR data by the comparative CT method
- (2008) Thomas D Schmittgen et al. Nature Protocols
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started